An HHS official implied Tuesday (July 10) the administration does not plan to do away with drug rebates entirely and instead is interested in banning rebates that are calculated as a percentage of list prices. “I think there will always be some form of negotiation off of list price,” HHS Deputy Assistance Secretary for Planning and Evaluation John O'Brien said a Pew Charitable Trust event. O'Brien said the administration would like the price that consumers pay to be similar to...